397 related articles for article (PubMed ID: 6304845)
1. [Dynamics of rifampicin and ethambutol resistance of strains of Koch bacilli isolated from patients with pulmonary tuberculosis 1973-1981].
Ionescu C; Timoşca S; Petreanu V; Petreanu C; Georgescu M; Martinescu T
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):315-20. PubMed ID: 6304845
[No Abstract] [Full Text] [Related]
2. [Causes of failure in neutralization, recovery and social rehabilitation of chronic eliminators of Koch bacilli treated with rifampin and ethambutol].
Barbu Z; Alexa M; Josefovics F
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(3):153-9. PubMed ID: 212812
[No Abstract] [Full Text] [Related]
3. [Survival of tuberculous bacilli in combined treatments including rifampicin].
Kreis B; Pretet S
Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
[No Abstract] [Full Text] [Related]
4. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
Pines A; Raafat H; Siddiqui GM
J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
[No Abstract] [Full Text] [Related]
5. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
Golyshevskaia VI; El'shanskaia MP
Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
[No Abstract] [Full Text] [Related]
6. [Study of some rifampicin and ethambutol resistant strains of Mycobacteria isolated in the vicinity of the district of Jassy].
Timoşca S; Petreanu V; Petreanu C; Ionescu L
Rev Med Chir Soc Med Nat Iasi; 1971; 75(1):119-25. PubMed ID: 5552548
[No Abstract] [Full Text] [Related]
7. [Clinical significance of drug resistance of tuberculosis mycobacteria and L-forms].
Golanov VS; Bogdalova VE; Andreev LP; Losin EI; Ushakova AG; Meshcheriakov VG; Bondin SV
Probl Tuberk; 1991; (12):27-8. PubMed ID: 1803368
[TBL] [Abstract][Full Text] [Related]
8. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
Constans P; Parrot R; Coury C
Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883
[No Abstract] [Full Text] [Related]
9. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
Delli Veneri F; Centrella G; Stefanelli R
Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
[No Abstract] [Full Text] [Related]
10. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
Anastasatu C; Sibila S
Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
[No Abstract] [Full Text] [Related]
11. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
12. [Study of rifampicin in the treatment of tuberculosis and nonspecific inflammatory lung diseases].
Rudoĭ NM; Zankisova IG; Eĭsaev BA
Antibiotiki; 1975 Oct; 20(10):945-8. PubMed ID: 813565
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity to Ethambutol and Rifampicin of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
Ceylon Med J; 1982 Jun; 27(2):75-9. PubMed ID: 6819093
[No Abstract] [Full Text] [Related]
15. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
Mkrtchian SV; Ushkin VV
Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
[No Abstract] [Full Text] [Related]
16. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
[TBL] [Abstract][Full Text] [Related]
17. [Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
Kozulicyna TI; Korotajev GA
G Ital Chemioter; 1972; 19(2):7-10. PubMed ID: 4199030
[No Abstract] [Full Text] [Related]
18. [Bacteriostatic activity of the blood in pulmonary tuberculosis and its clinical significance].
Alekseenko AM
Probl Tuberk; 1979 Jan; (1):33-7. PubMed ID: 105352
[No Abstract] [Full Text] [Related]
19. Short-course treatment regimens for patients with tuberculosis.
Dutt AK; Stead WW
Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
[No Abstract] [Full Text] [Related]
20. The requirement of capreomycin, ethambutol and rifampicin in chronic pulmonary tuberculosis in Helsinki on the basis of resistance indications.
Tani P
Scand J Respir Dis Suppl; 1969; 69():15-6. PubMed ID: 4313500
[No Abstract] [Full Text] [Related]
[Next] [New Search]
